Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Waning Immune Humoral Response to BNT162b2 Covid-19 Vaccine over 6 Months
E G Levin, Yaniv Lustig, Carmit Cohen, et al.
New England Journal of Medicine (2021) Vol. 385, Iss. 24
Open Access | Times Cited: 1083

Showing 26-50 of 1083 citing articles:

Severe COVID-19 outcomes after full vaccination of primary schedule and initial boosters: pooled analysis of national prospective cohort studies of 30 million individuals in England, Northern Ireland, Scotland, and Wales
Utkarsh Agrawal, Stuart Bedston, Colin McCowan, et al.
The Lancet (2022) Vol. 400, Iss. 10360, pp. 1305-1320
Open Access | Times Cited: 173
Modeling of waning immunity after SARS-CoV-2 vaccination and influencing factors
Laura Pérez‐Alós, José Juan Almagro Armenteros, Johannes Roth Madsen, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 162
Viral persistence, reactivation, and mechanisms of long COVID
Benjamin K. Chen, Boris Jülg, Sindhu Mohandas, et al.
eLife (2023) Vol. 12
Open Access | Times Cited: 139
Population antibody responses following COVID-19 vaccination in 212,102 individuals
Helen Ward, Matthew Whitaker, Barnaby Flower, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 135
Rapid increase in Omicron infections in England during December 2021: REACT-1 study
Paul Elliott, Barbara Bodinier, Oliver Eales, et al.
Science (2022) Vol. 375, Iss. 6587, pp. 1406-1411
Open Access | Times Cited: 135
Waning effectiveness of the third dose of the BNT162b2 mRNA COVID-19 vaccine
Tal Patalon, Yaki Saciuk, Asaf Peretz, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 135
COVID-19 vaccine-induced antibody responses in immunosuppressed patients with inflammatory bowel disease (VIP): a multicentre, prospective, case-control study
James L. Alexander, Nicholas A. Kennedy, Hajir Ibraheim, et al.
˜The œLancet. Gastroenterology & hepatology (2022) Vol. 7, Iss. 4, pp. 342-352
Open Access | Times Cited: 133
Understanding T cell responses to COVID-19 is essential for informing public health strategies
Santosha A. Vardhana, Lance Baldo, William G. Morice, et al.
Science Immunology (2022) Vol. 7, Iss. 71
Open Access | Times Cited: 118
Antibody-mediated neutralization of SARS-CoV-2
Henning Gruell, Kanika Vanshylla, Timm Weber, et al.
Immunity (2022) Vol. 55, Iss. 6, pp. 925-944
Open Access | Times Cited: 117
Characterization of the significant decline in humoral immune response six months post‐SARS‐CoV‐2 mRNA vaccination: A systematic review
Kin Israel Notarte, Israel Guerrero‐Arguero, Jacqueline Veronica Velasco, et al.
Journal of Medical Virology (2022) Vol. 94, Iss. 7, pp. 2939-2961
Open Access | Times Cited: 116
Efficacy and Safety of Ensitrelvir in Patients With Mild-to-Moderate Coronavirus Disease 2019: The Phase 2b Part of a Randomized, Placebo-Controlled, Phase 2/3 Study
Hiroshi Mukae, Hiroshi Yotsuyanagi, Norio Ohmagari, et al.
Clinical Infectious Diseases (2022) Vol. 76, Iss. 8, pp. 1403-1411
Open Access | Times Cited: 116
Vaccine effectiveness of heterologous CoronaVac plus BNT162b2 in Brazil
Thiago Cerqueira‐Silva, Srinivasa Vittal Katikireddi, Vinícius de Araújo Oliveira, et al.
Nature Medicine (2022) Vol. 28, Iss. 4, pp. 838-843
Open Access | Times Cited: 114
Waning immune responses against SARS-CoV-2 variants of concern among vaccinees in Hong Kong
Qiaoli Peng, Runhong Zhou, Yuewen Wang, et al.
EBioMedicine (2022) Vol. 77, pp. 103904-103904
Open Access | Times Cited: 113
Antibody Titers Before and After a Third Dose of the SARS-CoV-2 BNT162b2 Vaccine in Adults Aged ≥60 Years
Noa Eliakim‐Raz, Yaara Leibovici-Weisman, Amos Stemmer, et al.
JAMA (2021) Vol. 326, Iss. 21, pp. 2203-2203
Open Access | Times Cited: 112
Humoral responses after second and third SARS-CoV-2 vaccination in patients with immune-mediated inflammatory disorders on immunosuppressants: a cohort study
Luuk Wieske, Koos P J van Dam, Maurice Steenhuis, et al.
The Lancet Rheumatology (2022) Vol. 4, Iss. 5, pp. e338-e350
Open Access | Times Cited: 111
Rapid Diagnostic Testing for SARS-CoV-2
Paul K. Drain
New England Journal of Medicine (2022) Vol. 386, Iss. 3, pp. 264-272
Open Access | Times Cited: 110
Durability of Immune Response After COVID-19 Booster Vaccination and Association With COVID-19 Omicron Infection
Mayan Gilboa, Gili Regev‐Yochay, Michal Mandelboim, et al.
JAMA Network Open (2022) Vol. 5, Iss. 9, pp. e2231778-e2231778
Open Access | Times Cited: 110
Household transmission of the SARS-CoV-2 Omicron variant in Denmark
Frederik Plesner Lyngse, Laust Hvas Mortensen, Matthew Denwood, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 109
mRNA-based COVID-19 vaccine boosters induce neutralizing immunity against SARS-CoV-2 Omicron variant
Wilfredo F. García-Beltrán, Kerri St. Denis, Angelique Hœlzemer, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 104
Efficacy of booster doses in augmenting waning immune responses to COVID-19 vaccine in patients with cancer
Lauren C. Shapiro, Astha Thakkar, Sean Campbell, et al.
Cancer Cell (2021) Vol. 40, Iss. 1, pp. 3-5
Open Access | Times Cited: 103
COVID-19 vaccine – Long term immune decline and breakthrough infections
Johad Khoury, Ronza Najjar‐Debbiny, Ayman Hanna, et al.
Vaccine (2021) Vol. 39, Iss. 48, pp. 6984-6989
Open Access | Times Cited: 101
Persistent B cell memory after SARS-CoV-2 vaccination is functional during breakthrough infections
Sara Terreri, Eva Piano Mortari, M. Vinci, et al.
Cell Host & Microbe (2022) Vol. 30, Iss. 3, pp. 400-408.e4
Open Access | Times Cited: 99
Coronavirus Resistance Database (CoV-RDB): SARS-CoV-2 susceptibility to monoclonal antibodies, convalescent plasma, and plasma from vaccinated persons
Philip L. Tzou, Kaiming Tao, Sergei L. Kosakovsky Pond, et al.
PLoS ONE (2022) Vol. 17, Iss. 3, pp. e0261045-e0261045
Open Access | Times Cited: 93
Superior immunogenicity and effectiveness of the third compared to the second BNT162b2 vaccine dose
Yaniv Lustig, Tal Gonen, Lilac Meltzer, et al.
Nature Immunology (2022) Vol. 23, Iss. 6, pp. 940-946
Open Access | Times Cited: 92
Transmission and Infectious SARS-CoV-2 Shedding Kinetics in Vaccinated and Unvaccinated Individuals
Jiwon Jung, Ji Yeun Kim, Heedo Park, et al.
JAMA Network Open (2022) Vol. 5, Iss. 5, pp. e2213606-e2213606
Open Access | Times Cited: 92

Scroll to top